Resources for Occupational Safety and Health Administration (OSHA)

OSHA Prescribes 'Star' Status to Novartis Pharmaceuticals

www.ohsonline.com

East Hanover, N.J.-based Novartis Pharmaceuticals Corp. has earned "Star" status in OSHA's Voluntary Protection Program--the agency's highest level of corporate campus safety and health. A division of Novartis AG, globally headquartered in Basel., Switzerland, the East Hanover site develops and markets patent-protected prescription drugs in major therapeutic areas including immunology and infectious diseases, oncology and hematology, cardiovascular and metabolism, respiratory, and neuroscience and ophthalmics.

To achieve VPP status, Novartis showed a three-year average injury and illness rate that was at or below other employers in its industry. The East Hanover site underwent an extensive OSHA review of workplace conditions, safety records, employee safety and health programs, and regulatory compliance. As with all VPP Star sites, Novartis had to show that it is self-sufficient in its ability to control workplace hazards. Star participants are reevaluated every three to five years, although incident rates are reviewed annually.

View the Resource

Share or bookmarklet this web page at: